🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients

RecruitingPhase 1, Phase 2Ages 18 Years - anyAllMansoura University
NCT06903559 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients with kidney failure who require hemodialysis often suffer from anemia (low red blood cell count), heart and blood vessel problems, and a condition involving poor nutrition, inflammation, and hardening of the arteries (called MIA syndrome). Standard treatments for anemia often involve injections and iron supplements. This study aims to see if a newer oral medication, Roxadustat, works better than these standard treatments not only for anemia but also for improving cardiovascular health and the MIA syndrome. Participants in the study will be randomly assigned (like by chance) to one of two groups. One group will receive Roxadustat, while the other group will continue with their conventional anemia treatment. Researchers will compare the effects on heart function, markers of nutrition and inflammation, and anemia levels in both groups over a 6-month period.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age of patient is more than 18. * Patients who are willing to sign informed consent. * Patients with ESKD on chronic hemodialysis for more than 3 months. Exclusion Criteria: * Current pregnancy or lactation. * Patients with pre-existing malignancy. * Patients with psychosis or on hypnotics. * Refuse to participate in the study. * Known history of hematological disorders or other known causes for anemia other than CKD or dialysis. * Patients with severe cardiovascular disease
💊

What it tests

  • Roxadustat
  • Conventional Anemia Management
📍

Where

1 site
Urology and Nephrology Center, Mansoura University
Al Mansurah, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy